155 related articles for article (PubMed ID: 11208636)
41. Chronic obstructive pulmonary disease mortality in six U.S. cities.
Speizer FE; Fay ME; Dockery DW; Ferris BG
Am Rev Respir Dis; 1989 Sep; 140(3 Pt 2):S49-55. PubMed ID: 2782760
[TBL] [Abstract][Full Text] [Related]
42. Prognosis in chronic obstructive pulmonary disease.
Anthonisen NR; Wright EC; Hodgkin JE
Am Rev Respir Dis; 1986 Jan; 133(1):14-20. PubMed ID: 3510578
[TBL] [Abstract][Full Text] [Related]
43. Epigenetic change (GATA-4 gene methylation) is associated with health status in chronic obstructive pulmonary disease.
Meek PM; Sood A; Petersen H; Belinsky SA; Tesfaigzi Y
Biol Res Nurs; 2015 Mar; 17(2):191-8. PubMed ID: 24973415
[TBL] [Abstract][Full Text] [Related]
44. [Discriminative properties and validity of a health status questionnaire in obstructive airway disease patients: the Airway Questionnaire 20].
Camelier A; Rosa FW; Nascimento OA; Fernandes AL; Jardim JR
Arch Bronconeumol; 2007 Dec; 43(12):662-8. PubMed ID: 18053543
[TBL] [Abstract][Full Text] [Related]
45. Predicting cognitive decline in patients with hypoxaemic COPD.
Incalzi RA; Chiappini F; Fuso L; Torrice MP; Gemma A; Pistelli R
Respir Med; 1998 Mar; 92(3):527-33. PubMed ID: 9692117
[TBL] [Abstract][Full Text] [Related]
46. Body composition and health-related quality of life in patients with obstructive airways disease.
Shoup R; Dalsky G; Warner S; Davies M; Connors M; Khan M; Khan F; ZuWallack R
Eur Respir J; 1997 Jul; 10(7):1576-80. PubMed ID: 9230250
[TBL] [Abstract][Full Text] [Related]
47. Relationship between symptoms and health-related quality of life in chronic lung disease.
Viramontes JL; O'Brien B
J Gen Intern Med; 1994 Jan; 9(1):46-8. PubMed ID: 8133349
[TBL] [Abstract][Full Text] [Related]
48. Respiratory health status is associated with treatment outcomes in pulmonary tuberculosis.
Gupte AN; Selvaraju S; Paradkar M; Danasekaran K; Shivakumar SVBY; Thiruvengadam K; Dolla C; Shivaramakrishnan G; Pradhan N; Kohli R; John S; Raskar S; Jain D; Momin A; Subramanian B; Gaikwad A; Lokhande R; Suryavanshi N; Gupte N; Salvi S; Murali L; Checkley W; Golub JE; Bollinger R; Chandrasekaran P; Mave V; Gupta A
Int J Tuberc Lung Dis; 2019 Apr; 23(4):450-457. PubMed ID: 31064624
[TBL] [Abstract][Full Text] [Related]
49. Basal metabolic rate, weight loss and decline in FEV1 in COPD.
Congleton J; Green JH; Muers MF
Monaldi Arch Chest Dis; 1993 Oct; 48(5):539-40. PubMed ID: 8312921
[No Abstract] [Full Text] [Related]
50. Inhaled corticosteroids versus placebo for stable chronic obstructive pulmonary disease.
Yang IA; Ferry OR; Clarke MS; Sim EH; Fong KM
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD002991. PubMed ID: 36971693
[TBL] [Abstract][Full Text] [Related]
51. Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease.
Ni H; Aye SZ; Naing C
Cochrane Database Syst Rev; 2022 May; 5(5):CD013506. PubMed ID: 35616126
[TBL] [Abstract][Full Text] [Related]
52. Automatically Explaining Machine Learning Predictions on Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study.
Zeng S; Arjomandi M; Luo G
JMIR Med Inform; 2022 Feb; 10(2):e33043. PubMed ID: 35212634
[TBL] [Abstract][Full Text] [Related]
53. Developing a Machine Learning Model to Predict Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study.
Zeng S; Arjomandi M; Tong Y; Liao ZC; Luo G
J Med Internet Res; 2022 Jan; 24(1):e28953. PubMed ID: 34989686
[TBL] [Abstract][Full Text] [Related]
54. Impact of Lung Function and Exacerbations on Health-Related Quality of Life in COPD Patients Within One Year: Real-World Analysis Based on Claims Data.
Stöber A; Lutter JI; Schwarzkopf L; Kirsch F; Schramm A; Vogelmeier CF; Leidl R
Int J Chron Obstruct Pulmon Dis; 2021; 16():2637-2651. PubMed ID: 34588773
[TBL] [Abstract][Full Text] [Related]
55. Combination antibiotic therapy versus monotherapy in the treatment of acute exacerbations of chronic obstructive pulmonary disease: an open-label randomized trial.
Thu PNT; Huong MNT; Thi NT; Thanh HN; Minh KP
BMC Infect Dis; 2021 Sep; 21(1):1019. PubMed ID: 34587911
[TBL] [Abstract][Full Text] [Related]
56. A systematic review of literature to evaluate the burden of physical and psychological symptoms and palliative care in patients diagnosed with idiopathic pulmonary fibrosis.
van Jaarsveld MF; Gwyther L
Afr J Thorac Crit Care Med; 2019; 25(1):. PubMed ID: 34286243
[TBL] [Abstract][Full Text] [Related]
57. Validation of Clinical Characteristics and Effectiveness of Pulmonary Rehabilitation in a COPD Population with Discrepancy between Exercise Tolerance and FEV1.
Horie J; Takahashi K; Shiranita S; Anami K; Hayashi S
Healthcare (Basel); 2021 Jan; 9(1):. PubMed ID: 33419024
[TBL] [Abstract][Full Text] [Related]
58. Health-related quality of life associates with change in FEV
Lutter JI; Jörres RA; Kahnert K; Schwarzkopf L; Studnicka M; Karrasch S; Schulz H; Vogelmeier CF; Holle R;
BMC Pulm Med; 2020 May; 20(1):148. PubMed ID: 32471493
[TBL] [Abstract][Full Text] [Related]
59. Characteristics of Chronic Obstructive Pulmonary Disease Patients with Pulmonary Hypertension Assessed by Echocardiography in a Three-Year Observational Cohort Study.
Nakayama S; Chubachi S; Sakurai K; Irie H; Tsutsumi A; Hashiguchi M; Itabashi Y; Murata M; Nakamura H; Asano K; Fukunaga K
Int J Chron Obstruct Pulmon Dis; 2020; 15():487-499. PubMed ID: 32184586
[TBL] [Abstract][Full Text] [Related]
60. Factors influencing decline in quality of life in smokers without airflow obstruction: The COPDGene study.
Parekh TM; Bhatia S; Cherrington A; Kim YI; Lambert A; Iyer A; Regan EA; DeMeo DL; Han M; Dransfield MT
Respir Med; 2020 Jan; 161():105820. PubMed ID: 31759270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
